REQUEST A DEMO
Total
USD $0.00
Search more companies

Central-Pharma Bt (Hungary)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Electronic Shopping and Mail-Order Houses
Full name: Central-Pharma Bt Profile Updated: June 25, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Hungarian Download a sample report

Central-Pharma Bt is a company based in Hungary, with its head office in Csongrad. It operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on October 16, 1995. The total number of employees is currently 10 (2026). From the latest financial highlights, Central-Pharma Bt reported a net sales revenue increase of 7.83% in 2025. Its’ total assets recorded a growth of 24.73%. Central-Pharma Bt’s net profit margin decreased by 2.62% in 2025.

Headquarters
Fo u. 2-4. sz.
Csongrad; Csongrad; Postal Code: 6640

Contact Details: Purchase the Central-Pharma Bt report to view the information.

Basic Information
Total Employees:
Purchase the Central-Pharma Bt report to view the information.
Registered Capital:
Purchase the Central-Pharma Bt report to view the information.
Financial Auditors:
Purchase the Central-Pharma Bt report to view the information.
Incorporation Date:
October 16, 1995
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Central-Pharma Bt report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.83%
Total Operating Revenue
7.73%
Operating Profit
-43.92%
EBITDA
-29.8%
Net Profit/Loss for the Period
-62.73%
Total Assets
24.73%
Total Equity
-14.31%
Operating Profit Margin
-2.26%
Net Profit Margin
-2.62%
Return on Equity (ROE)
-19.37%
Quick Ratio
0.1%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?